We are hiring an ambitious and talented
for a fixed term period till 31.12.2022 starting at your earliest convenience. Contract extension is possible. A trial period of six months is applied.
Scientific Coordinator will
coordinate a large and well-funded breast cancer research program, which aims to translate preclinical laboratory-based breast cancer research to new clinically viable treatment modalities for breast cancer. The program is seeking new ways to sensitize breast cancer to immune checkpoint inhibitors via synthetic lethal and immunogenic cell death concepts, which are integrated with computational predictions.
One key investigational platform in this approach is a novel method to grow 3D cultures of intact fragments of patient-derived tissue (Patient-Derived Explant Cultures/PDECs) for analysis of tumor cell and tumor infiltrated lymphocyte responses (Haikala et al., Nature Comm. 2019; PMID: 30728358, Munne et al., Nature Comm. in press; Al-Akhrass et al., Mol. Oncol. 2021, PMID: 34564954). The program is funded by significant long-term grants from the US Department of Defense Breast Cancer Research Program, Business Finland, The Jane and Aatos Erkko Foundation, EU Horizon 2020, The Juselius Foundation, The Academy of Finland, the Finnish Cancer Organizations, and others.
The Finnish Translational Breast Cancer Research Program is led by FICAN Professor Juha Klefström, with his team located in the Faculty of Medicine* at the University of Helsinki. The program closely interacts with a number of leading translational breast cancer research teams in Finland, the EU and the USA, as well as with clinical oncologists in the HUS Comprehensive Cancer Center and the Finnish National Cancer Centre (FICAN) network.
The candidate will join a translational research group (https://klefstromlab.com) that is part of the Translational Cancer Medicine Research Program of the Medical Faculty’s Research Programs Unit (RPU; link). A list of publications from the host laboratory can be found at PubMed, search for Klefstrom+j. Highlights include publications in Nat. Comms (in press and 2019), Cancer Research, J. Med. Chem, Cancer Discovery, PNAS, Oncogene and EMBO J.
- PhD degree and several years of Principal Investigator, Scientific Coordinator or strong Post Doc experience in a relevant field
- Highly motivated and scientifically knowledgeable with strong interest in translational cancer research and working for cancer patients’ benefit
- Documented experience in translational cancer research
- Strong team player with outstanding communication and leadership skills
- Experience in grant writing, management and reporting
- Experience in supervising students and postdocs, working in expert teams and writing manuscripts
- As the working language of the research group and associated teams is English, the chosen candidate must be able to communicate fluently in English
THE CANDIDATE’S TASKS INCLUDE, BUT ARE NOT LIMITED TO:
- As part of the coordination team, you will coordinate interdisciplinary academic and entrepreneurial programs
- You will supervise both scientific and non-scientific personnel in Klefström’s research team and through collaborations in partner teams
- You will participate in writing, managing and reporting research grants
- You will participate in managing health related data, ethical and research permits, as well as a variety of contracts and agreements
- You will take responsibility of scientific communication within the programs and carry out general operational duties and implementation in various related research programs
- You will participate in planning of the translational research projects, oversee implementation of the projects and contribute to writing manuscripts
WHAT WE OFFER:
- A challenging international research-oriented position within a well-funded, ambitious and ground-breaking cancer research program
- Every day is different. You will perform a large set of diverse tasks, ensuring your professional development.
- Tight involvement in several multi-disciplinary translational research projects with broad national and international (EU and USA) exposure and multi-stakeholder involvement (academics, Pharma and other companies, oncologists, patient organizations)
- Opportunity to develop your leadership, communications and management skills through appointment in the strategic management team
- Opportunity to travel and develop networks nationally and internationally
- Opportunity to develop your publications list through co-authorship
The initial contract will be for one year, starting at your earliest convenience. Total program funding covers 5-years and contract extension is possible. The salary is in accordance with the University salary system (for teaching and research personnel).
Applications must include a CV and an application letter clearly describing how your profile matches the candidate requirements and other previous achievements in the field. Also include names and contact information of two or three references. The application, together with the required attachments, must be submitted via email to cancerio-office (at) helsinki.fi.
Deadline for applications is November 12 2021, but the position will be closed once a suitable candidate has been identified.
For further inquiries, please contact cancerio-office (at) helsinki.fi.